The actual importance of the thymus in both children and adults is largely unclear. In congenital cardiac surgery, a partial or total thymectomy is frequently performed to improve access to the heart and great vessels. We performed a literature search to evaluate the effect on the adaptive immune system of the removal of thymus tissue in patients with congenital heart disease. A PubMed search according to Dunning's standard provided 149 articles, of which 13 addressed our search question. Each study has been tabulated with author, cases, controls, follow-up, methods, results and limitations. A first group of articles repeatedly showed the effect on the T-cell compartment, including the impact on subgroups of this compartment. More recent studies, usually with a longer follow-up, confirm that the earlier changes in T-cell population appear to be permanent. Only one author found a normalization of T-cell population five years after thymectomy. In contrast to these clear changes in T-cell population, there is currently no clear clinical relevance. A literature search on thymectomy in congenital cardiac surgery revealed clear changes in T-cell-related immunity; however, there is a lack of clinical relevance. Further investigation of the adaptive immune system is required to explain this discrepancy.
INTRODUCTION
The thymus performs a crucial role in the development of T-cells by providing a microenvironment in which bone marrow progenitor cells proliferate and differentiate into mature T-cells. It is situated in the upper anterior mediastinum, right behind the sternum, partially covering the heart and great vessels [1] . In vertebrates, T-cell development depends on the presence of a functional thymus, which is variable during life. At birth, the thymus is almost fully developed, whereas it reaches its maximum output during adolescence. After this, the absolute volume starts to decrease while progressively transforming functional tissue into adipose tissue [2] . This process is known as the involution of the thymus. In contrast to this reduction in weight, size and activity, the thymus remains to serve as the principal site for T-cell differentiation and maturation through adulthood [1, 2] .
Little is known about the actual effect of thymectomy in the postnatal period. When a clear access and visualization of the heart and great vessels are needed, often a partial or total thymectomy is performed, such as in the correction of a transposition of the great vessels. Removal of the thymus gland to improve surgical access implies removal of the main source of T-cell differentiation, although other sources of differentiation have been described [3, 4] . A congenital hypoplasia or absence of the thymus gland, as seen in DiGeorge syndrome, can manifest in severe immunodeficiency, e.g. T-cell lymphopenia, delayed immunoglobulin (IgG) production and even absent T-cells [5] . By contrast, the immediate or late effects of thymectomy in various types of congenital cardiac pathology are less clear.
Experimental mouse models have shown that a thymectomy in neonatal mice-who still have an immature thymus-resulted in a partial immunodeficiency due to the cell-mediated immune response [6] . These findings were confirmed in a more recent study, where thymectomy induced a decreased maturation in the affinity of antibodies [7] . The thymus namely controls this maturation process through facilitating the selection of B-cells with highaffinity antibodies.
The changes and relevance of these changes after thymectomy in humans are less clear. It is uncertain which immunological transition takes place after a complete or partial thymectomy and what the actual clinical implications are. Nevertheless, a thymectomy is frequently performed-partial or complete-for the correction of congenital heart diseases (CHDs). This explains our literature search for clarifying possible immunological implications of removing the thymus in neonates with CHD.
MATERIALS AND METHODS
A literature study provides possible consequences of neonatal thymectomy in patients with CHD. In order to obtain the relevant articles in a structured and high sensitive manner, Dunning's principle was applied [8] . 
RESULTS
PubMed database delivered-with additional filters 'in human' and '1950-2012'-149 hits, of which all titles and abstracts were scanned, excluding all pre-existing pathology, such as Myasthenia Gravis and DiGeorge syndrome. Thirteen articles were eventually retained as relevant, almost all of which involving case-control studies. These articles were then tabulated according to author, cases, controls, follow-up, methods, results and limitations (chronologically arranged in Table 1 ).
According to the most recent study by Van Gent et al. a normalization of the T-cell pool can eventually be observed. A differentiation is made between the first 5 years of life and the window thereafter. In the first period, a significant decrease in CD4 + and CD8 + T-cells occurs, whereas after the initial 5 years, a normalization of the affected T-cell pool is to be expected.
Despite these findings of Van Gent et al., until now this recovery has not been confirmed in other studies. Halnon et al. [22] described a tendency for more eczema, contact allergies and rash in patients with no residual thymic tissue. Other significant changes in T cell receptor excision circles (TREC), T-cell receptor and T-regulating cells can be observed even after a period of 5-year post-thymectomy. Sauce et al. [19] also demonstrated an absolute decline in the CD4 + and CD8 + T-cell compartment in their patient group, ranging up to 22 years post-thymectomy. Additionally, they showed a loss of naive T-cells and an accumulation of oligoclonal memory cells. Finally, there seemed to be a strong T-cell response induced by cytomegalovirus (CMV), although this response was not compared with an appropriate control population, despite a lack of thymic output. Prelog et al. [18] confirmed these findings, whereas regeneration of thymic tissue was ruled out by different imaging methods or reinterventions [chest X-ray, computerized tomography (CT) and magnetic resonance imaging (MRI)].
Earlier studies suggested shifts in certain lymphocyte populations. Mancebo et al. [16] showed impaired long-term lymphocyte populations, mainly from the naive T-cell type. In addition, a significant decrease in TREC occurred and the total amount of cytokines increased. Torfadottir et al. [15] revealed a decrease in helper, naive and non-activated T-cells, whereas Madhok et al. [14] also detected a significant decrease of TREC when compared with preoperative values. Despite these observations, clinically relevant long-term effects remained absent. Halnon et al. [13] showed reduced TREC values as well as decreased lymphocytes (CD4 + , CD8
+ and naive CD4 + ) in the long term. Eysteinsdottir et al. showed less lymphocytes with lower proportions of CD3 + T-cells and T-helper cells. By contrast, neutrophil count increased, possibly reinforcing immunity in an adaptive response [12] . Turan et al. [10] and Wells et al. [11] showed decreased lymphocyte numbers. Brearley et al. [9] indicated a decline in white blood cells and neutrophils.
DISCUSSION
Cardiothoracic surgery and simultaneous thymectomy performed in early childhood, ensures rapid and significant changes in the peripheral blood image. Several studies showed that a thymectomy is responsible for immunological alterations; lower CD4 + and CD8 + T-cell levels, reduced proportions of 'recent thymic emigrants' and lower number of naive T-cells. The study by Van Gent et al. [24] -in contrast to other studiesshowed a normalization of this T-cell pool after five years. A slow recovery of the thymic tissue, as shown with MRI during the follow-up, might be a possible explanation for this tendency. However, given that some of the other cases have a follow-up of more than 5 years without residual thymus tissue, the reported findings of Van Gent et al. [25] were not uniformly confirmed. Nonetheless, X-ray of the chest might be a less sensitive method to rule out small residual thymus tissue. Halnon et al. mentioned a tendency for several symptoms (e.g. eczema, contact allergies and rash); however, further investigation of these symptoms did not show any statistical significance [23] .
A limitation in many studies is the lack of adequate assessment of residual thymus, although some succeeded in this evaluation [12, 14] . More accurate results are to be expected when a clear distinction between partial or total thymectomy can be made. Furthermore, opinions diverge on what the most reliable surface markers are for identifying the naive T-cell population. In adolescents, CD28 combined with CD45RA serve as markers to identify this population. Although CD4 + CD28 + CD45RA + generally is accepted as the identifier for the naive T-cell, this can vary in the older population [26] . CD62L, CCR7 and CD27 have also been suggested as detectors for the naive T-cell [27] . In the studies mentioned above, the naive T-cell is interpreted in different ways. Moreover, an important dilution effect of TREC occurs through peripheral T-cell proliferation [28] . In conclusion, TREC number is only an estimate of the thymus function.
Despite a wide variety in the follow-up, the available long-term studies did not unravel clinical relevant changes. It is often recommended to preserve thymus tissue as much as possible, although currently this recommendation seems to lack scientific background. In addition, the incidence of thymoma and thymus carcinoma in a subpopulation with thymus remnants is unknown.
Therefore, we feel that, if surgical access in CHD might be improved by a surgical thymectomy, this could be performed early in life safely even without leaving thymus remnant. Nonetheless, there might be a place for multicentric registration of patients undergoing neonatal thymectomy with the prospective follow-up of clinical and biochemical events to show currently unknown functional or clinical consequences of this procedure.
CONCLUSIONS
Although specific biochemical and immunological changes after thymectomy have been described, there are no reported clinical relevant changes related to a thymectomy for congenital cardiac surgery. Nonetheless, there might be a place for a multicentric registration of patients undergoing neonatal thymectomy with the prospective follow-up of clinical and biochemical events, such as infection, cancer and allergy development, to show currently unknown functional or clinical consequences of this procedure.
